Practice
Featured experience
Evergy $1.2 billion at-the-market offering
We advised the forward counterparties on the offering
IREN $1 billion convertible notes offering
We advised IREN on the offering
Kroger $5 billion accelerated share repurchase
Kroger will receive an initial delivery of approximately 65.6 million shares
PPL $2 billion at-the-market offering
We advised PPL on the offering
Theravance Biopharma, Inc. Follow-On Offering
Davis Polk advised the joint book-running managers in connection with a $115.1 million SEC-registered offering of 5,479,750…
Davis Polk Advises Verisk Analytics on the Sale of Its Health Care Services Business to Veritas Capital
Davis Polk is advising Verisk Analytics, Inc. in connection with the $820 million sale of Verisk’s health care services…
Davis Polk Advises Morgan Stanley on $3.5 Billion Senior Notes Offering
Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of $3.5 billion aggregate principal…
Davis Polk Advises Anacor Pharmaceuticals, Inc. on Its $287.5 Million Convertible Senior Notes Offering and Related Capped Call Transactions
Davis Polk advised Anacor Pharmaceuticals, Inc. in connection with its offering of $287.5 million aggregate principal amount…
Davis Polk Advises Atairos on Its Investment in Groupon
Davis Polk is advising Atairos on its $250 million investment in Groupon. Under the terms of the investment, Atairos is…
Regency Centers Corporation Forward Sale Agreement
Davis Polk acted as counsel to an affiliate of the counterparty in connection with the execution of a forward sale agreement…
Davis Polk Advises Markit on Its Merger with IHS
Davis Polk is advising Markit on its all-share merger of equals with IHS valued at more than $13 billion. The transaction is…
Ulta Salon, Cosmetics & Fragrance, Inc. $200 Million Accelerated Share Repurchase
Davis Polk advised the dealer manager in connection with a fixed-dollar, uncollared accelerated share repurchase transaction…
NuVasive, Inc. $650 Million Notes Offering
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by NuVasive, Inc. (“NuVasive”) of $650…
Pfizer Inc. $5 Billion Accelerated Share Repurchase
Davis Polk advised the counterparty in connection with an accelerated share repurchase transaction entered into between the…